Ackman: Allergan Rules For Shareholder Meetings Too Onerous - Presented by: The Aol. On Network

Allergan Inc, trying to fend off a hostile takeover bid from Valeant Pharmaceuticals International Inc, has stacked the odds against a special shareholders meeting. Pershing Square Capital Management, which is led by Bill Ackman, is attempting to muster at least 25 percent support of Allergan shares to hold a special meeting that could replace most of the Botox anti-wrinkle injection maker's board, which has refused to negotiate with Valeant.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 15.56 0.23 ▼ 1.46%
NOK $ 7.62 0.15 ▼ 1.93%
GE $ 27.25 0.03 ▼ 0.11%
AAPL $ 124.75 1.42 ▼ 1.13%
PBR $ 8.79 0.11 ▲ 1.27%
CMCSA $ 58.42 1.25 ▼ 2.09%
MSFT $ 41.615 0.55 ▼ 1.29%
QQQ $ 106.01 1.68 ▼ 1.56%

As of 4/17/2015, 04:15 PM